One-Year Surgical Outcomes and Quality of Life after Minimally Invasive Sling Procedures for the Treatment of Female Stress Urinary Incontinence: TVT SECUR(R) vs. CureMesh(R).
10.4111/kju.2010.51.5.337
- Author:
Young Min JOO
1
;
Jin Ho CHOE
;
Ju Tae SEO
Author Information
1. Department of Urology, Cheil General Hospital, Kwandong University College of Medicine, Seoul, Korea. jtandro@cgh.co.kr
- Publication Type:Comparative Study ; Original Article
- Keywords:
Minimally invasive surgical procedures;
Stress urinary incontinence;
Treatment outcome
- MeSH:
Achievement;
Cough;
Surveys and Questionnaires;
Female;
Follow-Up Studies;
Humans;
Lower Urinary Tract Symptoms;
Outpatients;
Quality of Life;
Self-Assessment;
Suburethral Slings;
Surgical Procedures, Minimally Invasive;
Treatment Outcome;
Urinary Bladder;
Urinary Incontinence;
Urodynamics
- From:Korean Journal of Urology
2010;51(5):337-343
- CountryRepublic of Korea
- Language:English
-
Abstract:
PURPOSE: We compared the efficacy and safety of two minimally invasive sling procedures used to treat female stress urinary incontinence (SUI), tension-free vaginal tape (TVT) SECUR(R) and CureMesh(R), and assessed the 1-year surgical outcomes. MATERIALS AND METHODS: Sixty women with SUI were assigned to undergo either the TVT SECUR (n=38) or CureMesh (n=22) procedures between April 2007 and June 2008. Patients were monitored via outpatient visits at 1 month, 3 months, and 1 year after surgery. The efficacy of these procedures was evaluated by the cough test or by a urodynamic study. At these postoperative visits, the patients also completed several questionnaires, including incontinence quality of life, patient's perception of urgency severity, the scored form of the Bristol Female Lower Urinary Tract Symptoms, visual analog scale, and questions about perceived benefit, satisfaction, and willingness to undergo the same operation again. The objective cure rate was defined as no leakage during the cough test with a full bladder. The subjective cure rate was evaluated by self-assessment of goal achievement performed 1 year postoperatively. RESULTS: The two groups were similar in preoperative characteristics and urodynamic parameters. The objective cure rates were similar between TVT SECUR and CureMesh (68.4% vs. 77.3%). All respondents reported improvement after surgery. There were no intra-operative complications. CONCLUSIONS: Our results showed that the TVT SECUR and CureMesh procedures are both safe and simple to perform and have no significant differences in efficacy. Comparative studies with long-term follow-up are warranted to determine the true efficacy of these procedures.
